Demographics and Outcomes of Initial Phase of COVID-19 Medicines Delivery Units Across 4 UK Centers During Peak B1.1.529 Omicron Epidemic : A Service Evaluation

© The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America..

Background: COVID-19 medicines delivery units (CMDU) were established in late December 2021 to deliver early antiviral therapy to patients classified as at risk with the aim of preventing hospitalization.

Methods: We performed a service evaluation at 4 CMDUs in England. We assessed demographics and triage outcomes of CMDU referral, uptake of antiviral therapy, and the rate of subsequent hospitalizations within 2 weeks of CMDU referral.

Results: Over a 3-week period, 4788 patients were referred and 3989 were ultimately assessed by a CMDU. Overall, 832 of the patients referred (17%) were judged eligible for treatment and 628 (13%) were ultimately prescribed an antiviral agent. The overall rate of admission within 14 days was 1%. Patients who were admitted were significantly older than those who did not require hospitalization. Of patients prescribed molnupiravir and sotrovimab, 1.8% and 3.2%, respectively, were admitted.

Conclusions: There was a high volume of referrals to CMDU service during the initial surge of the Omicron wave in the United Kingdom. A minority of patients were judged to be eligible for therapy. In a highly vaccinated population, the overall hospitalization rate was low.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:9

Enthalten in:

Open forum infectious diseases - 9(2022), 10 vom: 31. Okt., Seite ofac527

Sprache:

Englisch

Beteiligte Personen:

Brown, Michael [VerfasserIn]
Saund, Jasjot [VerfasserIn]
Qureshi, Azka [VerfasserIn]
Plowright, Megan [VerfasserIn]
Drury, Katie [VerfasserIn]
Gahir, Joshua [VerfasserIn]
Simpson, Tom [VerfasserIn]
Newman, Thomas [VerfasserIn]
Adams, Kate [VerfasserIn]
Galloway, James [VerfasserIn]
Durairaj, Kezia [VerfasserIn]
Elgizouli, Kamla [VerfasserIn]
Rampling, Tommy [VerfasserIn]
Cole, Joby [VerfasserIn]
Easom, Nicholas [VerfasserIn]
Goodman, Anna L [VerfasserIn]
Marks, Michael [VerfasserIn]

Links:

Volltext

Themen:

COVID-19
Journal Article
Molnupiravir
Sotrovimab

Anmerkungen:

Date Revised 21.02.2024

published: Electronic-eCollection

Citation Status PubMed-not-MEDLINE

doi:

10.1093/ofid/ofac527

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM348341938